ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $285,007 | -26.9% | 21,690 | -29.9% | 0.02% | -27.3% |
Q2 2023 | $389,844 | -32.0% | 30,940 | -29.6% | 0.02% | -35.3% |
Q1 2023 | $573,417 | -27.9% | 43,940 | -2.6% | 0.03% | -30.6% |
Q4 2022 | $795,388 | +2.4% | 45,090 | -11.6% | 0.05% | -7.5% |
Q3 2022 | $777,000 | -24.9% | 50,990 | -26.9% | 0.05% | -22.1% |
Q2 2022 | $1,035,000 | -45.0% | 69,760 | -16.5% | 0.07% | -34.6% |
Q1 2022 | $1,881,000 | -16.6% | 83,510 | -31.7% | 0.10% | -8.8% |
Q4 2021 | $2,256,000 | -4.9% | 122,271 | -31.1% | 0.11% | -12.3% |
Q3 2021 | $2,372,000 | -45.8% | 177,416 | -25.0% | 0.13% | -46.5% |
Q2 2021 | $4,378,000 | -29.0% | 236,515 | -42.4% | 0.24% | -34.3% |
Q1 2021 | $6,165,000 | -35.3% | 410,622 | -37.8% | 0.37% | -38.5% |
Q4 2020 | $9,532,000 | +69.0% | 660,102 | -4.7% | 0.60% | +44.7% |
Q3 2020 | $5,639,000 | +13.0% | 692,782 | -6.0% | 0.42% | +5.1% |
Q2 2020 | $4,991,000 | -8.6% | 737,262 | -5.0% | 0.40% | -24.9% |
Q1 2020 | $5,463,000 | -29.6% | 776,002 | -1.8% | 0.53% | -5.4% |
Q4 2019 | $7,757,000 | -9.9% | 790,352 | +0.8% | 0.56% | -17.5% |
Q3 2019 | $8,612,000 | +1.2% | 784,374 | +7.2% | 0.68% | +1.7% |
Q2 2019 | $8,508,000 | +34.9% | 731,589 | +10.7% | 0.66% | +29.9% |
Q1 2019 | $6,307,000 | +2.0% | 661,158 | +3.1% | 0.51% | -12.6% |
Q4 2018 | $6,181,000 | -32.2% | 641,188 | +0.2% | 0.58% | -20.1% |
Q3 2018 | $9,117,000 | +20.6% | 639,823 | +1.6% | 0.73% | +13.0% |
Q2 2018 | $7,559,000 | -0.3% | 629,903 | +2.7% | 0.65% | -4.8% |
Q1 2018 | $7,578,000 | -15.4% | 613,593 | -0.4% | 0.68% | -15.3% |
Q4 2017 | $8,961,000 | +1.6% | 615,883 | -0.7% | 0.80% | -8.3% |
Q3 2017 | $8,824,000 | +9.7% | 620,098 | -1.7% | 0.88% | +7.1% |
Q2 2017 | $8,047,000 | +1.7% | 630,668 | +1.1% | 0.82% | -2.0% |
Q1 2017 | $7,911,000 | +33.7% | 623,873 | +7.6% | 0.84% | +28.2% |
Q4 2016 | $5,919,000 | -17.3% | 579,758 | +6.7% | 0.65% | -19.1% |
Q3 2016 | $7,153,000 | +3.0% | 543,123 | -0.7% | 0.81% | -0.4% |
Q2 2016 | $6,943,000 | -2.1% | 546,718 | +1.8% | 0.81% | -2.5% |
Q1 2016 | $7,092,000 | -9.1% | 536,918 | +5.9% | 0.83% | -11.4% |
Q4 2015 | $7,799,000 | +25.1% | 507,068 | +0.8% | 0.94% | +20.6% |
Q3 2015 | $6,236,000 | -9.7% | 502,883 | -0.4% | 0.78% | -1.0% |
Q2 2015 | $6,909,000 | +14.9% | 505,028 | +0.5% | 0.78% | +15.3% |
Q1 2015 | $6,013,000 | +19.4% | 502,738 | +27.5% | 0.68% | +18.2% |
Q4 2014 | $5,035,000 | +3.2% | 394,288 | +8.4% | 0.58% | -1.0% |
Q3 2014 | $4,878,000 | -16.9% | 363,608 | -0.6% | 0.58% | -14.9% |
Q2 2014 | $5,871,000 | -12.4% | 365,791 | -1.6% | 0.68% | -14.8% |
Q1 2014 | $6,701,000 | +15.5% | 371,658 | -1.0% | 0.80% | +14.2% |
Q4 2013 | $5,802,000 | +2.7% | 375,315 | -1.3% | 0.70% | -4.9% |
Q3 2013 | $5,652,000 | +11.7% | 380,080 | -2.8% | 0.74% | +4.5% |
Q2 2013 | $5,061,000 | – | 391,150 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |